The DNAL1 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human A-549 lung adenocarcinoma epithelial cell line. This product provides a genetically defined loss-of-function model for the axonemal dynein light intermediate chain gene DNAL1, generated through CRISPR/Cas9-mediated gene disruption. The polyclonal format offers a heterogeneous pool of edited cells, enabling robust functional studies without clonal selection. This cell population is a valuable tool for examining ciliary motility and dynein arm biology within an epithelial context, facilitating investigations into motile ciliogenesis, signaling perturbations, and disease-relevant phenotypes. The knockout model is suited for a range of downstream assays, including high-speed video microscopy and immunofluorescence-based ciliary analyses.
The host A-549 cell line is a widely utilized, well-characterized model originally isolated from a human lung adenocarcinoma. These epithelial cells exhibit features of type II alveolar pneumocytes and can be differentiated into polarized, ciliated airway epithelial cells under appropriate culture conditions, such as air-liquid interface (ALI) culture. This capacity renders A-549 cells a relevant system for studying respiratory epithelial biology, ciliary function, and mucociliary clearance. The adenocarcinoma origin also permits cross-examination of ciliary defects and oncogenic signaling, as dysregulated Hedgehog pathway activity has been linked to both ciliopathies and lung cancer progression.
At the molecular level, DNAL1 encodes a light intermediate chain that integrates into the outer dynein arm of motile cilia, playing an essential role in dynein arm assembly and stability. The transcription of DNAL1 is regulated by FOXJ1 and RFX family transcription factors (such as RFX3), master regulators of ciliogenesis. The DNAL1 protein interacts with the axonemal dynein heavy chains DNAH5 and DNAH11, the light intermediate chain DNALI1, and the thioredoxin domain-containing protein TXNDC3 to form functional dynein motor complexes. Disruption of DNAL1 leads to impaired ciliary beating, compromised mucociliary clearance, and downstream alterations in Hedgehog signaling, as primary cilia serve as coordinators of this pathway.
In the A-549 cellular context, DNAL1 knockout offers a physiologically relevant model for primary ciliary dyskinesia (PCD), including Kartagener syndrome, a disorder characterized by defective ciliary motility, recurrent respiratory infections, and situs inversus. The cell population permits dissection of motile ciliary assembly pathways and the functional consequences of dynein arm defects. Researchers can explore how DNAL1 loss influences ciliary beat frequency, ciliary length, and the trafficking of dynein components, as well as broader epithelial differentiation and barrier function. The model further enables studies of mucociliary clearance dynamics, a critical defense mechanism of the airway epithelium.
This DNAL1 knockout cell population is well-suited for investigating ciliary biology, disease mechanisms, and therapeutic interventions for ciliopathies. Representative applications include high-content immunofluorescence staining of ciliary markers (e.g., acetylated ??-tubulin, DNAH5), high-speed video microscopy to quantify ciliary beat frequency, western blotting to assess dynein arm component expression, RT-qPCR analysis of ciliary gene expression, and ALI culture to model mucociliary epithelium. These cells can be employed in drug screening for agents that restore or bypass ciliary function, or in mechanistic studies examining FOXJ1-/RFX3-mediated transcriptional networks. For further details or custom solutions, please contact Ascent Research.
